Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village”

• Autor(a) principal: Zuleima Caballero
• Data de Publicação: 2022
• Outros Autores: Ximena Norero, Dora Estripeaut, David Ellis, Catalina Raggi, Kanix Wang, Catherine Castro, Davina Moossazadeh, Margarita Ramirez, Abhinav Pandey, Kevin Ashi, Samantha Dovgin, Ashtyn Dixon, Xuan li, Ian Begeman, Sharon Heichman, Aliya Moreira, Joseph Lykins, Delba Villalobos-cerrud, Lorena Fabrega, José Luis Sanchez Montalvo, Connie Mendivil, Mario r. Quijada, Silvia Fernández-pirla, Valli de la Guardia, Digna Wong, Mayrene Ladrón de Guevara, Andrew Grose, Carlos Flores, Jovanna Borace, Anabel García, Natividad Caballero, Claudia Rengifo-herrera, Maria Theresa Moreno de Saez, Michael Politis, Stephanie Ross, Mimansa Dogra, Vishan Dhamsania, Karen Leahy, Nicholas Graves, Marci Kirchberg, Kopal Mathur, Ashley Aue, Carlos m. Restrepo, Alejandro Llanes, German Guzman, Arturo Rebellon, Kenneth Boyer, Peter Heydemann, Ying Zhou, a. Gwendolyn Noble, Charles Swisher, Peter Rabiah, Shawn Withers, Teri Hull, Chunlei su, Michael Blair, Paul Latkany, Fatima Alibana Clouser, Ernest Mui, Daniel Vítor de Vasconcelos Santos, Alcibiades Villareal, Ambar Perez, Carlos Andrés Naranjo Galvis, Mónica Vargas Montes, Nestor Ivan Cardona Perez, Morgan Ramirez, cy Chittenden, Edward Wang, Maryam Siddiqui, Laura Lorena Garcia-lópez, Guillermo Padrieu, Juliana Muñoz-ortiz, Nicolás Rivera-valdivia, María Cristina Bohorquez-granados, Gabriela Castaño De-la-torre, Juan David Valencia Hernandez, Daniel Celis-giraldo, Juan Alejandro Acosta Dávila, Elizabeth Torres, Nicole Leong, Manuela Mejia Oquendo, José y. Arteaga-rivera, Dan l Nicolae, Andrey Rzhetsky, Nancy Roizen, Eileen Stillwaggon, Larry Sawers, Francois Peyron, Martine Wallon, Emanuelle Chapey, Mariangela Soberónfelín, Perpetua Goodall, Pauline Levigne, Carmen Charter, Migdalia de Frias, Jose Montoya, Cindy Press, Raymund Ramirez, Despina Contopoulos-ioannidis, Yvonne Maldonado, Oliver Liesenfeld, Carlos Gomez, Morgan Michalowski, Kelsey Wheeler, Samantha Zehar, James Mcauley, Denis Limonne, Sandrine Houze, Sylvie Abraham, Raphael Piarroux, Vera Tesic, Kathleen Beavis, Ana Abeleda, Mahmoud Ismail, Mari Sautter, Bouchra el Mansouri, Adlaoui el Bachir, Fatima Amarir, Kamal el Bissati, Ellen Holfels, David Frim, David Mclone, Richard Penn, William Cohen, Monica Christmas, Alejandra De-la-torre, Gabrielle Britton, Jorge Motta, Eduardo Ortega-barria, Isabel Luz Romero, Paul Meier, Michael Grigg, Jorge Gómez-marín, Jagannatha Rao Kosagisharaf, Xavier Sáez Llorens, Stephen Schrantz, Osvaldo Reyes, Rima Mcleod
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFMG
• Texto Completo: https://doi.org/10.1007/s40124-022-00268-x; http://hdl.handle.net/1843/61744; http://orcid.org/0000-0002-1130-9631; https://orcid.org/0000-0002-6747-2024
• topic: Congenital toxoplasmosis; Diagnostic testing; Prenatal screening; Point-of-care testing; Antiparasitic treatment; Marginalized populations; Técnicas e Procedimentos Diagnósticos; Toxoplasmose Congênita; Diagnóstico Pré-Natal; Testes Imediatos

Purpose of Review Review international efforts to build a global public health initiative focused on toxoplasmosis with spillover benefits to save lives, sight, cognition and motor function benefiting maternal and child health. Recent Findings Multiple countries’ efforts to eliminate toxoplasmosis demonstrate progress and context for this review and new work. Summary Problems with potential solutions proposed include accessibility of accurate, inexpensive diagnostic testing, pre-natal screening and facilitating tools, missed and delayed neonatal diagnosis, restricted access, high costs, delays in obtaining medicines emergently, delayed insurance pre-approvals and high medicare copays taking considerable physician time and effort, harmful shortcuts being taken in methods to prepare medicines in settings where access is restricted, reluctance to perform ventriculoperitoneal shunts promptly when needed without recognition of potential benefit, access to resources for care, especially for marginalized populations, and limited use of recent advances in management of neurologic and retinal disease which can lead to good outcomes.